| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.02B | +42.1% |
| Cost of Revenue | $381.5M | +29.1% |
| Gross Profit | $642.6M | +51.1% |
| R&D Expense | $332.3M | +21.6% |
| SG&A Expense | $191.0M | +3.2% |
| Operating Income | $119.3M | +463.2% |
| Interest Expense | $6.7M | -78.3% |
| Pre-tax Income | $129.9M | +392.2% |
| Income Tax | $38.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $499.9M | -53.5% |
| Short-term Investments | $692.0M | -28.3% |
| Accounts Receivable | $71.4M | -27.3% |
| Inventory | $100.4M | +103.7% |
| Current Assets | $1.46B | -34.7% |
| Total Assets | $2.17B | -26.7% |
| Current Liabilities | $185.8M | -72.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $26.5M | -7.2% |
| Financing Cash Flow | -$887.1M | +31.7% |
| +186.4% |
| Net Income | $91.4M | -95.7% |
| EPS (Basic) | $2.61 | -94.7% |
| EPS (Diluted) | $2.54 | -94.7% |
| Total Liabilities |
| $764.4M |
| +2.5% |
| Stockholders' Equity | $1.41B | -36.5% |